The store will not work correctly when cookies are disabled.
2-(6,7-Dimethoxy-2,3-dihydro-benzo[1,4]dioxin-2-yl)-4,5-dihydro-1H-imidazole
ID: ALA169624
PubChem CID: 44380654
Max Phase: Preclinical
Molecular Formula: C13H16N2O4
Molecular Weight: 264.28
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc2c(cc1OC)OC(C1=NCCN1)CO2
Standard InChI: InChI=1S/C13H16N2O4/c1-16-8-5-10-11(6-9(8)17-2)19-12(7-18-10)13-14-3-4-15-13/h5-6,12H,3-4,7H2,1-2H3,(H,14,15)
Standard InChI Key: BNOKWNSPVOHILS-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
1.1292 -1.7917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8500 -2.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5625 -1.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4167 -2.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4167 -3.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2958 -1.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1292 -3.4542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6500 -0.9792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2958 -3.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0083 -2.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0083 -3.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3167 -2.1417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8500 -3.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7208 -1.8042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7250 -3.4542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4542 -0.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8667 -1.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7208 -0.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7250 -4.2792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 1 1 0
5 4 1 0
6 4 2 0
7 5 1 0
8 3 2 0
9 5 2 0
10 6 1 0
11 10 2 0
12 3 1 0
13 2 1 0
14 10 1 0
15 11 1 0
16 8 1 0
17 12 1 0
18 14 1 0
19 15 1 0
7 13 1 0
11 9 1 0
17 16 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 264.28 | Molecular Weight (Monoisotopic): 264.1110 | AlogP: 0.85 | #Rotatable Bonds: 3 |
Polar Surface Area: 61.31 | Molecular Species: BASE | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.62 | CX LogP: 0.45 | CX LogD: -0.76 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.88 | Np Likeness Score: 0.44 |
References
1. Chapleo CB, Myers PL, Butler RC, Doxey JC, Roach AG, Smith CF.. (1983) alpha-adrenoreceptor reagents. 1. Synthesis of some 1,4-benzodioxans as selective presynaptic alpha 2-adrenoreceptor antagonists and potential antidepressants., 26 (6): [PMID:6133953] [10.1021/jm00360a008] |